0001562180-20-003588.txt : 20200513 0001562180-20-003588.hdr.sgml : 20200513 20200513182912 ACCESSION NUMBER: 0001562180-20-003588 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200511 FILED AS OF DATE: 20200513 DATE AS OF CHANGE: 20200513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDSMITH MARK A CENTRAL INDEX KEY: 0001246842 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38584 FILM NUMBER: 20874759 MAIL ADDRESS: STREET 1: 925 PAGE MILL ROAD CITY: PALO ALTO STATE: CA ZIP: 94304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CONSTELLATION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001434418 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-714-0555 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2020-05-11 false 0001434418 CONSTELLATION PHARMACEUTICALS INC CNST 0001246842 GOLDSMITH MARK A C/O CONSTELLATION PHARMACEUTICALS, INC. 215 FIRST STREET, SUITE 200 CAMBRIDGE MA 02142 true false true false Common Stock 2020-05-11 4 M false 100.00 1.55 A 143163.00 I Owned by Trusts for which Mark A. Goldsmith is a Trustee Common Stock 2020-05-11 4 S false 100.00 50.00 D 143063.00 I Owned by Trusts for which Mark A. Goldsmith is a Trustee Common Stock 2020-05-12 4 M false 2625.00 1.55 A 145688.00 I Owned by Trusts for which Mark A. Goldsmith is a Trustee Common Stock 2020-05-12 4 M false 300.00 11.50 A 145988.00 I Owned by Trusts for which Mark A. Goldsmith is a Trustee Common Stock 2020-05-12 4 M false 1300.00 7.60 A 147288.00 I Owned by Trusts for which Mark A. Goldsmith is a Trustee Common Stock 2020-05-12 4 S false 4225.00 50.0531 D 143063.00 I Owned by Trusts for which Mark A. Goldsmith is a Trustee Stock Option (right to buy) 1.55 2020-05-11 4 M false 100.00 0.00 D 2021-03-10 Common Stock 100.00 17612.00 D Stock Option (right to buy) 1.55 2020-05-12 4 M false 2625.00 0.00 D 2021-03-10 Common Stock 2625.00 14987.00 D Stock Option (right to buy) 11.50 2020-05-12 4 M false 300.00 0.00 D 2028-07-18 Common Stock 300.00 6825.00 D Stock Option (right to buy) 7.60 2020-05-12 4 M false 1300.00 0.00 D 2028-03-07 Common Stock 1300.00 12446.00 D These trades were made pursuant to a Rule 10b5-1 trading plan. This transaction was executed in multiple trades at prices ranging from $50.00 to $50.49. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Shares are fully vested. This option was granted on July 19, 2018. The shares underlying the option are scheduled to vest in equal quarterly installments through July 19, 2021. This option was granted on March 8, 2018. The shares underlying the option are scheduled to vest in equal quarterly installments through March 8, 2021. /s/ Emma Reeve, as Attorney-in-Fact for Mark A. Goldsmith 2020-05-13